Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
A Review of the Utility and Limitations of Artificial Intelligence in Retinal Disorders and Pediatric Ophthalmology
6
Zitationen
4
Autoren
2024
Jahr
Abstract
Artificial intelligence (AI) is reshaping ophthalmology by enhancing diagnostic precision and treatment strategies, particularly in retinal disorders and pediatric ophthalmology. This review examines AI's efficacy in diagnosing conditions such as diabetic retinopathy (DR) and age-related macular degeneration (AMD) using imaging techniques, such as optical coherence tomography (OCT) and fundus photography. AI also shows promise in pediatric care, aiding in the screening of retinopathy of prematurity (ROP) and the management of conditions, including pediatric cataracts and strabismus. However, the integration of AI in ophthalmology presents challenges, including ethical concerns regarding algorithm biases, privacy issues, and limitations in data set quality. Addressing these challenges is crucial to ensure AI's responsible and effective deployment in clinical settings. This review synthesizes current research, underscoring AI's transformative potential in ophthalmology while highlighting critical considerations for its ethical use and technological advancement.
Ähnliche Arbeiten
Optical Coherence Tomography
1991 · 13.577 Zit.
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs
2016 · 7.234 Zit.
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
2014 · 6.714 Zit.
YOLOv3: An Incremental Improvement
2018 · 5.881 Zit.
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 · 5.816 Zit.